Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Blood draws, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test."
- "Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study."
- "Blood sample collection will occur during normal routine clinic visits."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests a new way to find breast cancer by looking for changes to DNA in blood samples. It is for adults who get care at UMMS and can speak and understand English. The study lasts about 5 years and includes blood draws at regular clinic visits, a review of medical records, and questionnaires.
The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You are 18 or older.
- You get care at UMMS.
- You are willing and able to agree to the study procedures.
- You can speak and understand English.
Who can't join
- You are younger than 18.
- You do not get care at UMMS.
- You cannot agree to the study procedures.
- You cannot speak or understand English.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * 18 years old or older * Patient of UMMS * Willing and able to consent to study procedures listed in the protocol * Ability to speak and understand English Exclusion Criteria: * Younger than 18 years old * Patient not cared for at UMMS * Unable to consent to study procedures listed in the protocol * Unable to speak or understand English
Study sites (1)
MD
- University of Maryland Baltimore Washington Medical Center · Glen Burnie, MD 21061Peter Olivieri, MD · Study contact · 410-553-8241 · polivieri@umm.eduCynthia Drogula, MD · Sub-investigatorJeffrey Marshall, MD · Sub-investigatorHarvinder Singh, MD · Sub-investigatorMore trials in Glen Burnie